Physician profile
David Schnur
NPI 1669442208
$566.12
in general payments reported to CMS, 2019-2025
8 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2021: $60.79 · 2022: $21.35 · 2023: $73.68 · 2024: $40.66 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319 · Education: $19.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.63 |
| Education | $19.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $286.31 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Axogen | $108.52 | 2019 | |
| Abbvie INC. | $56.84 | 2023-2025 | Botox |
| Stryker Corporation | $37.74 | 2019 | |
| Integra Lifesciences Corporation | $25.50 | 2023 | Durasorb Monofilament Mesh |
| Dilon Technologies, INC. | $24.36 | 2024 | Hemoblast Bellows |
| Cardinal Health 414 LLC | $19.09 | 2025 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Biocomposites INC | $7.76 | 2023 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schnur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.